This report presents a strategic analysis of the Australia Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies, and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Australia Patient Support Programs (PSP) Market, offering unmatched value, accuracy, and expert insights.

1. Australia Patient
Support Program
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2021 – 2030F)

2. This report presents a strategic analysis of the Australia Patient Support
Program market and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, characteristics, main players, trends and insights,
growth and demand drivers, challenges & future outlook, etc. This is one of
the most comprehensive reports about the Australia Patient Support
Program market, and offers unmatched value, accuracy, and expert
insights

3. Table of
Contents
• Market Overview
• Growth Drivers & Restraints
• Market Segmentation
• Major Market Share
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Future Opportunities
• Conclusion

4. 4 A Sample Report on Australia Patient Support Program Market I Confidential
Table of Contents
1. Australia Patient Support Program Market Overview………………..……….……………………………....................................6
1.1 Market size and forecast
1.2 Patient support programs: What do they offer?
2. Market Growth Drivers and Restraints …………………………………………………………………….…………….…………….9
2.1 Market Growth Drivers
2.1.1 Rising number of collaborations and partnerships between stakeholders
2.1.2 Increasing adoption of digital therapeutics and remote monitoring solutions
2.1.3 Implementation of government regulations and initiatives to promote patient-centric care
2.2 Market Restraints
2.2.1 Patient needs are unique and vary by region
2.2.2 Formulary restrictions and cost-sharing
3. Market Segmentation……………………………………………………………….…………………..…………………..………….….15
3.1 By caregiver access
3.2 By healthcare financing

5. 5 A Sample Report on Australia Patient Support Program Market I Confidential
Table of Contents (continued)
4. Major Products Market Share………………………..…………………………………………………………………..…………....…19
4.1 Market analysis, insights and forecast - By revenue
5. Competitive Landscape……………………………………………………..……………………...…………..…................................21
5.1 Major companies for Australia market
6. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ……………………..…….......23
6.1 AstraZeneca
6.2 GSK
6.3 Abbvie
6.4 Vaitris
7. Healthcare Policies and Regulatory Landscape…………………………………………………….……………………..………....28
7.1 Regulatory framework of Australia patient support program market
8. Factors Driving Future Growth………………………………………………………………………………………………..………....30
8.1 Recent developments in patient support program
9. Future Opportunities…………………..…………..………………………………….………………………………………………......32
9.1 Future Opportunities
10. Conclusion……………………………..…………..………………………………….………………………………………………......34

6. Australia Patient Support Program Market Analysis
1. Overview

7. 7 A Sample Report on Australia Patient Support Program Market I Confidential
▪ Australia Patient Support Program (PSP) stood at around
USD XX Bn in 2021 and is projected to reach USD XX Bn
by 2030, exhibiting a CAGR of XX % during the forecast
period
▪ Pharmaceutical companies play a key role in supporting
the quality use of medicines through patient focused
programs. These programs are designed to aid
compliance and lifestyle choices
▪ PSPs provide significant value to patients through the
accessibility of information and support and the
participation is only available to patients who have been
already prescribed a medicine and supported by their
healthcare professional
SAMPLE
Key Analysis
1.1 Market size & forecast
$ XX
$ XX
Australia Patient Program Market Forecast (2022-2030F)

8. 8 A Sample Report on Australia Patient Support Program Market I Confidential
1.2 Patient support programs: What do they offer?
Patient Support Programs (PSPs)
Patient Access Programs
Named Patient
Programs (NPP)
Financial
Assistance
Programs
Patient Adherence Programs
Loyalty Programs
Patient Education
Programs
Convenience Programs
Other Support
Programs

9. Australia Patient Support Program Market Analysis
2. Growth Drivers & Restraints

10. 10 A Sample Report on Australia Patient Support Program Market I Confidential
Market growth drivers and restraints
Increasing adoption of
digital therapeutics and
remote monitoring
solutions
Rising number of
collaborations and
partnerships between
stakeholders
Implementation of
government regulations
and initiatives to promote
patient-centric care
Patient needs are unique
and vary by region
Restraints
Drivers
Formulary restrictions and
cost-sharing

11. 11 A Sample Report on Australia Patient Support Program Market I Confidential
2.1.1 Rising number of collaborations and partnerships between stakeholders
▪ As many patient organizations work with pharma industry on various different levels – from knowledge sharing to
financial support – it is key to shape those relationships in a transparent way
2.1 Market growth drivers

12. 12 A Sample Report on Australia Patient Support Program Market I Confidential
Market growth drivers (continued)
2.1.2 Increasing adoption of digital therapeutics and patient engagement solutions
▪ Increasing use of digital technology in the patient support program helps patient and the care giver to track the
health condition including the proper guidance to patient whenever and wherever required
▪ Increasing trend of delivering patient engagement experiences across digital marketing channels to interact with
patients, helping them stay engaged with their health

13. 13 A Sample Report on Australia Patient Support Program Market I Confidential
Market growth drivers (continued)
2.1.3 Implementation of government regulations and initiatives to promote patient-centric care
▪ Favorable government initiatives are likely to impact market growth in the coming years. The Australian
government has clearly defined the patient support programs having an objective of the healthcare and well-
being of the patients including the emotional as well as the financial support

14. 14 A Sample Report on Australia Patient Support Program Market I Confidential
2.2.1 Patient needs are unique and vary by
regions
2.2 Market restraints
▪ There is opportunity to leverage learnings, but
there’s no plug-and-play method when it comes
to PSPs
▪ What is successful for one product in one region,
will struggle to be directly lifted into a new region
namely because across countries and regions
the patient journey will differ
2.2.2 Formulary restrictions and cost-
sharing
▪ More than half faced a formulary restriction, and
some abandoned due to cost
▪ For launch and mature brands alike, that access
increasingly comes with higher patient cost-
sharing and utilization restrictions such as prior
authorization and step therapy

15. Australia Patient Support Program Market Analysis
3. Market Segmentation

16. 16 A Sample Report on Australia Patient Support Program Market I Confidential
Patient Support Program Market Segmentation
Australia patient support program market segmentation
Caregiver Access
Healthcare at Home
Patient Transportation
Remote Monitoring
Virtual Care/ Telehealth
Health Coaching
Healthcare Financing
Alternative Coverage / PAPs
Benefit Coverage (BI/PA/Appeal)
Co-pay assistance
Reimbursement Support

17. 17 A Sample Report on Australia Patient Support Program Market I Confidential
▪ Remote patient monitoring enables monitoring of patients
outside conventional clinical settings thereby increasing
access to care and reducing healthcare delivery costs
▪ Home healthcare is a supportive care provided by medical
professionals at patient’s home for the purpose of
promoting, maintaining or restoring health or maximizing
the level of independence while minimizing the effects of
disability and illness
3.1 Market segmentation: By caregiver access
Patient Support Program Market Share by Caregiver Access
(2021)
Virtual Care/
Telehealth
Remote
Monitoring
Healthcare at
Home
Patient
Transportation
Health
Coaching
Key Insights

18. 18 A Sample Report on Australia Patient Support Program Market I Confidential
▪ Electronic Prior Authorization (ePA)- it is the electronic
transmission of information between the prescriber, and
payer to determine whether or not the PA is granted
▪ Reimbursement Support - Services remove barriers to
successful payment of claims and provide a resource for
patients with coverage-related questions
3.2 Market segmentation: By healthcare financing
Patient Support Program Market Share by Healthcare Financing
(2021)
Benefit Coverage
(BI/PA/Appeal)
Co-pay Assistance Alternative
Coverage / PAPs
Reimbursement
Support
Key Insights

19. Australia Patient Support Program Market Analysis
4. Major Market Share

20. 20 A Sample Report on Australia Patient Support Program Market I Confidential
4.1 Major patient support program operators
Key Insights
▪ From the pharmaceutical company’s perspective, PSPs contribute to better patient outcomes overall, and as the industry shifts
more toward outcomes-based payment models, enhancing actual patient outcomes will be a crucial success element
▪ A strong patient support program will influence the approval of treatments and market authorizations and will boost patient
enrollment

21. Australia Patient Support Program Market Analysis
5. Competitive Landscape

22. 22 A Sample Report on Australia Patient Support Program Market I Confidential
5.1 Major players revenue (current and forecast)
Major Market Revenue of Patient Support Services
Companies ($Bn)
AstraZeneca GSK Abbvie Viatris
Revenue share used for PSP Other revenue
SAMPLE
Key Insights

23. Australia Patient Support Program Market Analysis
6. Key Company Profiles

24. 24 A Sample Report on Australia Patient Support Program Market I Confidential
6.1 AstraZeneca
• The AstraZeneca Patient Support Programs help patients
navigate the complexities of reimbursement and provide
support during the journey of their treatment
• Connect360, AstraZeneca Oncology patient support programs
are some of the PSPs going on currently
Company Name: AstraZeneca
Year of Establishment: 1999
Headquarter: Cambridge, US
Revenue (EU): $37.4 Bn (2021)
Website: www.astrazeneca.com
Company at a Glance
Company Overview

25. 25 A Sample Report on Australia Patient Support Program Market I Confidential
6.2 GSK
• GSK has patient support program named NuYou Support that is
being offered to the Australian patients
• GSK provides the access to its Asthma drugs Nucala and the
access to helpful resources for treatment in Australia
Company Name: GSK
Year of Establishment: 2000
Headquarter: Brentford, UK
Revenue (EU): $33.3 Bn (2021)
Website: www.gsk.com/en-gb/
Company at a Glance
Company Overview

26. 26 A Sample Report on Australia Patient Support Program Market I Confidential
6.3 Abbvie
Company at a Glance
Company Overview
Company Name: Abbvie
Year of Establishment: 2013
Headquarter: Illinois, US
Revenue (EU): $14.8Bn (2021)
Website: www.abbvie.com/
• In Australia Abbvie have created patient support programs that
currently benefit more than 14,000 patient lives and help
support them for better health outcomes
• AbbVie’s patient support and services go far beyond basic
disease information with support programs that enable them to
remain as active and independent as possible and ensure
optimal care

27. 27 A Sample Report on Australia Patient Support Program Market I Confidential
6.4 Viatris
• Viatris has MyEpiPen® Patient Support Program for Australian
patients. Australia’s 35,000-member EpiClub® program has
been revamped and rebranded by Viatris (formerly Mylan) as
the MyEpiPen® Patient Support Program
Company at a Glance
Company Overview
Company Name: Viatris
Year of Establishment: 1961
Headquarter: Pennslyvania, US
Revenue (EU): $11.9 Bn (2021)
Website: www.viatris.com

28. Australia Patient Support Program Market Analysis
7. Healthcare Policy and Regulatory Landscape

29. 29 A Sample Report on Australia Patient Support Program Market I Confidential
7.1 Regulatory framework of Australia patient support program market
▪ The Department of Health in Australia has defined as - The healthcare and wellbeing of patients must be the only
objective of a Patient Support Program
▪ Rules and key pointers:
▪ Any payments should be included in the company’s reporting of financial support, grants etc. in the interests of
being open and transparent about the conduct and management of a PSP
▪ In relation to data that is collected in a Patient Support Program, the Department suggests there should be
further clarification of the types of information that can be communicated to healthcare professionals

30. Australia Patient Support Program Market Analysis
8. Factors Driving Future Growth

31. 31 A Sample Report on Australia Patient Support Program Market I Confidential
8.1 Recent developments in patient support program
▪ Pharma manufacturers often use training materials to create awareness for these programs, a channel growing in
popularity is actively participating in the patient journey — more specifically, connectivity with electronic health
records (EHRs) systems to augment education. These integrations builds improved awareness for providers,
growing program adoption
▪ As more specialty products come to the market, compressing onboarding time through technology solutions for both
prior authorizations and electronic benefits investigations will ensure patients get on (and stay on) therapies

32. Australia Patient Support Program Market Analysis
9. Future Opportunities

33. 33 A Sample Report on Australia Patient Support Program Market I Confidential
9.1 Future Opportunities
▪ AI, machine learning and natural language processing tools can identify both clinical and socioeconomic data points
to ensure patient support teams are spending time with the right patients, particularly with those who may be closer
to nonadherence

34. Australia Patient Support Program Market Analysis
10. Conclusion

35. 35 A Sample Report on Australia Patient Support Program Market I Confidential
10.1 Conclusion
1
2
3
5
4
Strong Demand
With the implementation of
government norms towards
patient centricity there is an
increase demand
Emerging Initiative
Increasing pressure on the
pharma companies to help
patients with the access of their
drugs is done through various
initiatives
Growing Technology
Advancements
With the emerging technology
and the transformation from
paper to digital, companies are
offering virtual care to patients
and HCPs
Support for the HCPs
Patient support programs are
also assisting HCPs to deliver
healthcare virtually with the
comfort of being at their home
during COVID-19 pandemic
Advancement in healthcare
delivery
PSPs would enhance the way
healthcare was delivered to the
patient earlier, with new
innovations coming up that will
help to reduce the overall cost
of treatment

36. Methodology & Scope

37. 37 A Sample Report on Australia Patient Support Program Market Analysis I Confidential
Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

38. 38 A Sample Report on Australia Patient Support Program Market Analysis I Confidential
Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

39. 39 A Sample Report on Australia Patient Support Program Market Analysis I Confidential
Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

40. 40 A Sample Report on Australia Patient Support Program Market Analysis I Confidential
Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

41. 2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

42. The report is prepared
using a proven
methodology and
insightful research
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

43. About

44. www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

45. Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

46. Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

47. Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

48. Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

49. Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

50. Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

51. Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors . With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

52. 7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

53. Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
Whatsapp: (+91) 931 639 7935
We would be happy to help.